REGN Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals Inc is an integrated biopharmaceutical company. It discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.
$684.70 +23.56 (3.56%)
As of 05/23/2022 14:13:06 EST IEX book CBOE book
Security Information
Category1:
US EquityCategory2:
Common stocksCategory3:
Large cap
GICS sector: Health Care
Industry: Biotechnology
Index country: USA
Country of incorporation: USA
IPO date: 03/01/2001
Outstanding shares: 108,028,048
Average volume: 631,957
Market cap: $70,990,631,743
Current dividend yield: 0.00%
All SEC filings:
SEC Edgar Online
Quarterly filings:
10-Q
Annual filings:
10-K
Sedol: 2730190
Valuation (See tab for details)
PE ratio: 9.00
PB ratio: 3.57
PS ratio: 4.30
Return on equity: 39.84%
Net income %: 48.06%